Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Voyageur Secures First International Sales Contract worth US$1.9 Million (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Veracyte Inc VCYT

Healthcare Biotechnology
Veracyte, Inc. is a global diagnostics company. The Company enables clinicians with insights they need to guide and assure patients. The Company offers tests for thyroid cancer (Afirma), prostate cancer (Decipher Prostate), breast cancer (Prosigna), interstitial lung diseases (Envisia), and bladder cancer (Decipher Bladder). Its Percepta Nasal Swab test is being run in its Clinical Laboratory... see more

Recent & Breaking News (NDAQ:VCYT)

Veracyte to Present at 10th Annual SVB Leerink Global Healthcare Conference

Business Wire February 18, 2021

Veracyte Announces Fourth Quarter and Full-Year 2020 Financial Results

Business Wire February 17, 2021

Veracyte to Present at BTIG Virtual MedTech, Digital Health, Life Science & Diagnostic Tools Conference

Business Wire February 11, 2021

Veracyte to Release Fourth Quarter and Full-Year 2020 Financial Results on February 17, 2021

Business Wire February 10, 2021

Veracyte Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares

Business Wire February 9, 2021

Veracyte Announces Pricing of Upsized Public Offering of 7,432,433 Shares of Common Stock

Business Wire February 4, 2021

Veracyte Announces Proposed Public Offering of Common Stock

Business Wire February 3, 2021

Veracyte to Acquire Decipher Biosciences

Business Wire February 3, 2021

Veracyte Announces Preliminary Fourth Quarter and Full-Year 2020 Financial Results

Business Wire February 3, 2021

Veracyte to Participate in 23rd Annual Needham Virtual Growth Conference

Business Wire January 6, 2021

Bayer and Veracyte Announce Precision Oncology Collaboration in Thyroid Cancer

Business Wire December 22, 2020

Veracyte Announces ISO 13485:2016 Certification for Its In Vitro Diagnostics Quality Management System

Business Wire December 21, 2020

Veracyte Announces New Preliminary Data for Its In-Development Lung Cancer Portfolio Tests

Business Wire December 16, 2020

Veracyte to Host Virtual Lung Cancer R&D Day on Wednesday, December 16, 2020

Business Wire December 3, 2020

Veracyte to Participate in Piper Sandler 32nd Annual Virtual Healthcare Conference

Business Wire November 23, 2020

Veracyte Announces New General Manager Structure to Advance Global Expansion

Business Wire November 17, 2020

Veracyte Announces Third Quarter 2020 Financial Results

Business Wire November 2, 2020

Veracyte Announces New Data Published in Journal of Clinical Oncology Suggest the Prosigna Breast Cancer Test's Genomic Underpinning Drives Prognostic Performance

Business Wire October 30, 2020

Veracyte Announces Publication of Manuscript Describing Scientific Rigor Behind Next-Generation Percepta Genomic Sequencing Classifier

Business Wire October 22, 2020

Veracyte Announces New Data Reinforcing Foundational Technology of Nasal Swab Test for Early Lung Cancer Detection Presented at CHEST Annual Meeting 2020

Business Wire October 19, 2020